These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2386826)

  • 1. [Membrane mechanisms of the effect of alkylating cytostatic agents].
    Mukhin VV; Poda GI; Luĭk AI; Baldenkov GN
    Biull Eksp Biol Med; 1990 Apr; 109(4):351-3. PubMed ID: 2386826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
    Ihlenfeldt M; Gantner G; Harrer M; Puschendorf B; Putzer H; Grunicke H
    Cancer Res; 1981 Jan; 41(1):289-93. PubMed ID: 6256062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
    Sallés J; Wallace MA; Fain JN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repair of DNA-protein cross-links induced by antineoplastic alkylating agents].
    Lomova TIu; Shakhova IK; Shkodinskaia EN
    Biull Eksp Biol Med; 1981 Jul; 92(7):74-6. PubMed ID: 7295949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of bone marrow homotransplantation on the toxicity and antineoplastic property of some alkylating agents].
    Veksler IG; Shevchenko VN
    Vopr Onkol; 1965; 11(7):71-6. PubMed ID: 4956684
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of some alkylating antiblastic drugs and antimetabolites on the healing process of fracture foci. (Experimental research)].
    Mangione F; Taverna L
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1711-2. PubMed ID: 5877911
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of alkylating antitumor agents on the binding of DNA to protein.
    Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B
    Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of the chemical structure on the biological tendency of cytostatic compounds related to dibromomanitol. II. Mechanism of action.
    Horváth IP; Institóris L
    Arzneimittelforschung; 1967 Feb; 17(2):149-55. PubMed ID: 5631482
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formation of precipitation areas in immunization with the alkylating compounds Lonin-3 and K-4].
    Montsevichiute-Eringene
    Biull Eksp Biol Med; 1968 Mar; 65(3):91-4. PubMed ID: 4967813
    [No Abstract]   [Full Text] [Related]  

  • 10. The lack of effects of alkylating agents on mammalian cell membranes.
    Ankel EG; Ring BJ; Lai CS; Holcenberg JS
    Int J Tissue React; 1986; 8(5):347-54. PubMed ID: 3023251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkylating agents.
    Connors TA
    Cancer Chemother Biol Response Modif; 1990; 11():29-44. PubMed ID: 2223396
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromosomal aberration due to cytostatic agents.
    Stacher A; Novotny H; Ruzicka F; Schuhfried G
    Int J Clin Pharmacol; 1974 Jun; 9(4):250-7. PubMed ID: 4422172
    [No Abstract]   [Full Text] [Related]  

  • 13. Alkylating agents and DNA polymerases.
    Bignold LP
    Anticancer Res; 2006; 26(2B):1327-36. PubMed ID: 16619541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: A comparison of tumour sensitivity to cytostatic agents during in vivo and in vitro culture.
    Bullen BR; Russell CW; Giles GR
    Br J Surg; 1976 Aug; 63(8):660. PubMed ID: 953488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytostatic agents and male fertility].
    Wildschut J; den Ottolander GJ; Hartgrink-Groeneveld CA
    Ned Tijdschr Geneeskd; 1976 Mar; 120(10):412-7. PubMed ID: 1250434
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumour alkylating agents: cytotoxic action and organ toxicity.
    Connors TA
    IARC Sci Publ; 1986; (78):143-5. PubMed ID: 3583387
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alkylating nucleosides. Synthesis and cytostatic activity of new types of halomethyl-substituted nucleosides].
    Pérez Méndez-Castrillón MP
    Rev Esp Oncol; 1984; 31(1):7-13. PubMed ID: 6545430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biology of alkylating-agent cellular injury.
    Shulman LN
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):325-35. PubMed ID: 8468267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylating agents.
    Connors TA
    Cancer Chemother Biol Response Modif; 1992; 13():31-44. PubMed ID: 1389913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.